论文部分内容阅读
本文对我院20年来(1975.5—1995.5)收治的86例子宫肉瘤病案进行回顾性临床分析,探讨与预后有关的危险因素,寻求更好的治疗方法,期望获得较好的治愈率。经研究分析,结果:二年、五年生存率分别是45.7％和35.0％。认为与本病预后相关的危险因素有病理分类,临床期别,子宫大小及是否绝经等。病理类型中,子宫平滑肌肉瘤获得相对高些生存率,二年、五年、十年生存率分别为38.0％,30.0％和14.0％,而宫内膜间质肉瘤和中胚混合瘤二年、五年生存率分别是28.3％,23.1％和22.3％,11.1％(P<0.01)。
This article retrospectively analyzed 86 cases of uterine sarcoidosis treated in our hospital for 20 years (1975.5-1995.5), explored the risk factors related to prognosis, sought better treatment and expect to get a better cure rate. After research and analysis, the results: two-year, five-year survival rates were 45.7% and 35.0%. The risk factors associated with the prognosis of the disease that pathological classification, clinical stage, the size of the uterus and whether menopause. Pathological types, uterine leiomyosarcoma to obtain a relatively high survival rate, two years, five years, ten-year survival rates were 38.0%, 30.0% and 14.0%, respectively, and endometrial stromal sarcoma and mesothelioma mixed tumor two years, The five-year survival rates were 28.3%, 23.1% and 22.3%, respectively, and 11.1% (P <0.01).